Developmental Cell Impact Factor

Among Developmental Biology journals, Developmental Cell ranks in the top 5% by impact factor (JCR 2024). This ranking is based on our analysis of 20,449 journals in the Clarivate JCR 2024 database.

The trend shows a gradual decline from the 2021 peak, consistent with the broader post-pandemic citation normalization. In developmental biology specifically, the field did not benefit from the massive COVID-driven citation boost that elevated medical and immunology journals, so the decline is more muted. The current 8.7 is lower than the journal's recent highs but still firmly Q1 and #2 in its category.

In developmental biology, JIF ranges are naturally lower than in biomedicine or materials science. The field has fewer researchers, papers tend to cite more selectively, and the total citation pool is smaller. An 8.7 JIF in developmental biology carries more field-specific weight than the same number would in oncology or chemistry.

Developmental Cell is one of only a handful of journals that the developmental biology community treats as a top-tier venue. The other comparison points are Development (Company of Biologists), Genes & Development (CSHL), and the broader Cell Press family. Among these, Developmental Cell has the strongest Cell Press branding and the broadest developmental biology scope.

The five-year JIF of 11.4 is particularly telling. It means Developmental Cell papers are cited 30% more frequently over five years than over two years, which indicates that work published here becomes a lasting part of the field's reference literature.

Developmental Cell editors want work that reveals new mechanisms in development, tissue biology, or stem cell function. The bar is:

• mechanistic depth and developmental relevance, not descriptive observation
• work that matters to the broad developmental biology community
• experimental completeness that meets Cell Press standards
• a story that extends understanding of how development works, not just what happens

Descriptive phenotypic studies without mechanistic insight tend to get redirected.

It does not tell you whether the mechanistic depth is sufficient, whether your model organism will satisfy Cell Press reviewers, or whether the developmental biology community will see the work as field-advancing. The JIF places the journal correctly in the upper tier of developmental biology. The submission decision should turn on mechanistic depth, developmental relevance, and Cell Press editorial expectations.

For Developmental Cell, the five-year pattern matters because developmental biology papers often become reference points more slowly than fast-moving oncology or methods papers. A page like this should help authors read that correctly. The journal's value is in durable field relevance and Cell Press selectivity for mechanism, not in chasing the biggest two-year citation spike.

That makes the shortlist question practical: does the paper have enough mechanistic developmental logic, completeness, and community relevance to justify this audience, or is it better framed for a neighboring journal with a different identity?

• It helps when you are choosing between Developmental Cell, Genes & Development, EMBO Journal, and broader Cell Press options.
• It helps when the manuscript reveals a durable developmental mechanism that the field is likely to keep citing.
• It misleads when the story is mostly descriptive phenotype or a generic stem-cell paper without enough developmental logic.
• It misleads when authors treat a lower two-year JIF as evidence that the journal is weak rather than simply slower-burn in citation behavior.

In our pre-submission review work with developmental biology manuscripts, three patterns are most predictive of desk rejection at Developmental Cell:

In vitro-only developmental claims. Developmental Cell reviewers expect in vivo validation of any developmental mechanism. Papers using only cell culture, organoids, or ex vivo explants to support claims about how development works in a living organism will return from review with requests for animal model validation, almost without exception. If in vivo data isn't in the paper, it needs to be in the plan before submission. "Future work will validate in vivo" is not a sufficient response to this expectation; editors know when a paper is being submitted before it's ready for this journal.

Descriptive phenotyping without epistasis. Cell Press standards require mechanistic completeness. A paper that identifies a new gene required for morphogenesis and characterizes the phenotype thoroughly with quantitative imaging and multiple markers, but doesn't place the gene in a signaling pathway or establish epistatic relationships, will be returned. "Gene X is required for Y" is the beginning of a Developmental Cell paper, not the end of one. Reviewers expect to see where X fits in the signaling logic, tested genetically, overexpression rescue, double mutant epistasis, or domain mapping that identifies the functional mechanism.

Development-framed papers that haven't been rewritten for Cell Press. Development and Developmental Cell have different intended readerships. Development's audience is the developmental biology specialist community. Developmental Cell's audience is the broader Cell Press readership: molecular biologists, cell biologists, and stem cell researchers who may not follow the developmental biology literature closely. Papers submitted to Developmental Cell with framing that assumes deep familiarity with the developmental biology background (papers that read like Development submissions with a higher ambition) consistently hit desk rejection for insufficient breadth. The introduction, framing, and significance need to speak to a reader who understands Cell Press biology but isn't a developmental specialist.

Submit if:

• The paper reveals a developmental mechanism with clear in vivo validation and multiple orthogonal experimental approaches
• The mechanistic story is complete, you know what the gene or pathway does, how it does it, and where it fits in the developmental logic
• The developmental finding has consequences that matter to cell biologists and molecular biologists beyond the developmental biology community
• The work uses in vivo models that developmental biologists trust (mouse, zebrafish, Drosophila, C. elegans, Xenopus, or organoid models with in vivo validation)

Think twice if:

• The validation is entirely in vitro or organoid-only, Dev Cell reviewers will request in vivo data
• The developmental phenotype is the main finding and the mechanism is still descriptive
• Cell Stem Cell (for stem-cell-heavy work) or Nature Cell Biology would be stronger fits given the biology
• The paper still reads like a Development submission rather than a Cell Press submission in scope and framing

• Developmental Cell submission guide
• Developmental Cell submission process
• Is Developmental Cell a good journal?

The two-year IF tells part of the story. Here's the complete JCR profile for Developmental Cell:

The self-citation gap is tiny (just 0.1) which means the IF isn't propped up by authors citing themselves in the same journal. That's a good sign. The 8.7-year cited half-life is unusually long, even by developmental biology standards. Papers published here don't spike and fade; they become reference literature. Developmental Cell sits at #2 in Developmental Biology behind Development by category tradition, but it's part of the Cell Press family, which gives it broader visibility across molecular and cell biology audiences that Development doesn't naturally reach. The JCI of 2.29 (where 1.0 is average for the field) confirms the journal punches well above its category weight.

Dev Cell doesn't exist in isolation, it's part of a family of journals with overlapping scope but different editorial bars. Knowing where each title sits helps you target correctly.

The practical distinction that matters most: Developmental Cell wants complete developmental mechanisms (signaling pathways, fate decisions, morphogenetic processes) with clear in vivo validation. Cell Reports will take strong mechanistic work that doesn't need a developmental biology framing. If the paper's developmental angle is secondary to the molecular mechanism, Cell Reports is often a better and faster path. If development is the whole point and the mechanism is complete, Dev Cell is the right target.

Cell Press review standards are demanding everywhere, but at Developmental Cell they're specifically demanding about developmental biology rigor. Reviewers here aren't just checking that the experiments work, they're checking that the developmental logic is airtight.

The unwritten rule at Dev Cell: if a reviewer can say "this could be a snapshot artifact rather than a developmental process," the paper will come back for revision. The journal's identity depends on publishing work that captures how development actually works, not just what it looks like at one moment. A Developmental Cell submission readiness check can flag whether your developmental logic has gaps before Cell Press reviewers do.